Quick Takeaways
- This page summarizes Daniel M. Junius's Form 4 filing for GLYCOMIMETICS INC (GLYC).
- 1 reported transaction and 1 derivative row are listed below.
- Filing timestamp: 01 May 2024, 16:24.
Daniel M. Junius - 01 May 2024 Form 4 Insider Report for GLYCOMIMETICS INC (GLYC)
- Role
- Director
- Signature
- /s/ Brian F. Leaf, Attorney-in-Fact
- Issuer symbol
- GLYC
- Transactions as of
- 01 May 2024
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 01 May 2024, 16:24:33 UTC
- Previous filing
- 02 Apr 2024
- Next filing
- 08 May 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"Daniel M. Junius filed Form 4 for GLYCOMIMETICS INC (GLYC) on 01 May 2024."
What Changed
- Previous filing in this sequence was filed on 02 Apr 2024.
- Current net transaction value: $0.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | GLYC | Stock Option (right to buy) | Award | $0 | +40,000 | $0.000000 | 40,000 | 01 May 2024 | Common Stock | 40,000 | $1.62 | Direct | F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | The shares underlying this option vest on May 1, 2025, subject to the reporting person's continuous service as of such vesting date. |